{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:59:01Z","timestamp":1784689141773,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T00:00:00Z","timestamp":1621641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Taibah University Medical Sciences"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jtumed.2021.04.009","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:07:11Z","timestamp":1622678831000},"page":"700-705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Abuse liability of gabapentin in the Saudi population after the pregabalin restriction: A cross-sectional study"],"prefix":"10.1016","volume":"16","author":[{"given":"Amina A.","family":"Alkhalaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raneem A.","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham A.","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah O.","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5067-2441","authenticated-orcid":false,"given":"Aisha F.","family":"Badr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jtumed.2021.04.009_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsps.2011.11.003","article-title":"Dispensing medications without prescription at Saudi community pharmacy: extent and perception","volume":"21","author":"Al-Mohamadi","year":"2013","journal-title":"Saudi Pharmaceut J"},{"issue":"24","key":"10.1016\/j.jtumed.2021.04.009_bib2","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1001\/jama.2008.892","article-title":"Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States","volume":"300","author":"Qato","year":"2008","journal-title":"J\u00a0Am Med Assoc"},{"issue":"7","key":"10.1016\/j.jtumed.2021.04.009_bib3","doi-asserted-by":"crossref","first-page":"E345","DOI":"10.1503\/cmaj.109-4158","article-title":"Oxycodone class action lawsuit filed","volume":"184","author":"Webster","year":"2012","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jtumed.2021.04.009_bib4","series-title":"The government tenders and procurement law","year":"2019"},{"key":"10.1016\/j.jtumed.2021.04.009_bib5","unstructured":"Saudi Food and Drug Administration. \u201cFood and Drug\": withdrawal of pregabalin preparation from pharmacies urgently. Retrieved at: https:\/\/www.sfda.gov.sa\/ar\/drug\/news\/pages\/drug29-05-2015a1.aspx. (Accessed: 2016 Dec 27)."},{"issue":"11","key":"10.1016\/j.jtumed.2021.04.009_bib6","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2146\/ajhp090313","article-title":"Withdrawal symptoms after gabapentin discontinuation","volume":"67","author":"Hellwig","year":"2010","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"10.1016\/j.jtumed.2021.04.009_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.pra.0000358318.73684.df","article-title":"Gabapentin-induced delirium and dependence","volume":"15","author":"Kruszewski","year":"2009","journal-title":"J\u00a0Psychiatr Pract"},{"issue":"5","key":"10.1016\/j.jtumed.2021.04.009_bib8","article-title":"Abuse of combinations of gabapentin and quetiapine","volume":"16","author":"Reeves","year":"2014","journal-title":"Prim Care Companion CNS Disord"},{"issue":"6","key":"10.1016\/j.jtumed.2021.04.009_bib9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1176\/appi.ajp.2014.13111526","article-title":"Potentiation of the effect of buprenorphine\/naloxone with gabapentin or quetiapine","volume":"171","author":"Reeves","year":"2014","journal-title":"Am J Psychiatr"},{"issue":"6","key":"10.1016\/j.jtumed.2021.04.009_bib10","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1213\/01.ane.0000287643.13410.5e","article-title":"Pregabalin: its pharmacology and use in pain management","volume":"105","author":"Gajraj","year":"2007","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.jtumed.2021.04.009_bib11","first-page":"229","article-title":"Mersfelder WHN. Gabapentin: abuse, dependence, and withdrawal","volume":"50","author":"Tracey","year":"2015","journal-title":"Ann Pharmacother: SAGE J"},{"issue":"10","key":"10.1016\/j.jtumed.2021.04.009_bib12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","article-title":"A\u00a0comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"Bockbrader","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jtumed.2021.04.009_bib13","unstructured":"Food and Drug administration: Pregabalin (Lyrica) ref. ID: 2911805. highlights of prescribing information. Retrieved from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/021446s028lbl.pdf."},{"key":"10.1016\/j.jtumed.2021.04.009_bib14","unstructured":"Food and Drug administration: Gabapentin (neurontin) ref. ID: 2911805. FDA approved labeling text dated 03\/01\/2011. Retrieved from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/020235s036,020882s022,021129s022lbl.pdf."},{"issue":"6","key":"10.1016\/j.jtumed.2021.04.009_bib15","first-page":"559","article-title":"Examination of the evidence for off-label use of gabapentin","volume":"9","author":"Mack","year":"2003","journal-title":"J\u00a0Manag Care Pharm"},{"issue":"4","key":"10.1016\/j.jtumed.2021.04.009_bib16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and misuse of pregabalin and gabapentin","volume":"77","author":"Evoy","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.jtumed.2021.04.009_bib17","doi-asserted-by":"crossref","first-page":"f6747","DOI":"10.1136\/bmj.f6747","article-title":"Bad medicine: gabapentin and pregabalin","volume":"347","author":"Spence","year":"2013","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.jtumed.2021.04.009_bib18","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/add.13324","article-title":"Gabapentin misuse, abuse and diversion: a systematic review","volume":"111","author":"Smith","year":"2016","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jtumed.2021.04.009_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/1574886309666141022101956","article-title":"Pregabalin dependence: a case report","volume":"10","author":"Halaby","year":"2015","journal-title":"Curr Drug Saf"},{"issue":"9","key":"10.1016\/j.jtumed.2021.04.009_bib20","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1517\/13543784.2012.703179","article-title":"Pregabalin in clinical psychiatry and addiction: pros and cons","volume":"21","author":"Martinotti","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10.1016\/j.jtumed.2021.04.009_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4088\/JCP.v68n0320a","article-title":"Gabapentin abuse, and delirium tremens upon gabapentin withdrawal","volume":"68","author":"Pittenger","year":"2007","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"10","key":"10.1016\/j.jtumed.2021.04.009_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002396","article-title":"Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study","volume":"14","author":"Gomes","year":"2017","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.jtumed.2021.04.009_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40264-017-0595-1","article-title":"All-cause and drug-related medical events associated with overuse of gabapentin and\/or opioid medications: a retrospective cohort analysis of a commercially insured US population","volume":"41","author":"Peckham","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.jtumed.2021.04.009_bib24","series-title":"\u201cSaudi Arabia social media statistics 2019\u201d Global social media insights","year":"2019"},{"issue":"4","key":"10.1016\/j.jtumed.2021.04.009_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17041334","article-title":"Knowledge, attitudes, and beliefs regarding drug abuse and misuse among community pharmacists in Saudi Arabia","volume":"17","author":"Mobrad","year":"2020","journal-title":"Int J Environ Res Publ Health"},{"issue":"4","key":"10.1016\/j.jtumed.2021.04.009_bib26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.17712\/nsj.2016.4.20160245","article-title":"Patients reasons for obtaining psychotropic medications without a prescription at retail pharmacies in Central Saudi Arabia","volume":"21","author":"Alosaimi","year":"2016","journal-title":"Neurosciences (Riyadh)"},{"issue":"1","key":"10.1016\/j.jtumed.2021.04.009_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/bcp.12277","article-title":"Misuse of the gamma-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK","volume":"78","author":"Kapil","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.jtumed.2021.04.009_bib28","first-page":"605","article-title":"Potential for pregabalin abuse or diversion after past drug-seeking behavior","volume":"110","author":"Filipetto","year":"2010","journal-title":"J\u00a0Am Osteopath Assoc"},{"issue":"2","key":"10.1016\/j.jtumed.2021.04.009_bib29","first-page":"147","article-title":"Concerns about pregabalin: further experience with its potential of causing addictive behaviors","volume":"7","author":"Gahr","year":"2013","journal-title":"J\u00a0Addict Med"},{"issue":"Suppl 1","key":"10.1016\/j.jtumed.2021.04.009_bib30","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.drugalcdep.2005.10.020","article-title":"Abuse of prescription drugs and the risk of addiction","volume":"83","author":"Compton","year":"2006","journal-title":"Drug Alcohol Depend"}],"container-title":["Journal of Taibah University Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361221000986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361221000986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:29:18Z","timestamp":1761647358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1658361221000986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1658361221000986"],"URL":"https:\/\/doi.org\/10.1016\/j.jtumed.2021.04.009","relation":{},"ISSN":["1658-3612"],"issn-type":[{"value":"1658-3612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abuse liability of gabapentin in the Saudi population after the pregabalin restriction: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Journal of Taibah University Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtumed.2021.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Production and hosting by Elsevier Ltd on behalf of Taibah University.","name":"copyright","label":"Copyright"}]}}